State MI
Clinical Trials in Michigan
Michigan is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Michigan and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 319 actively recruiting studies with Michigan sites out of 319 registered in total. The busiest research areas in Michigan are Prostate Cancer, Advanced Solid Tumor, Solid Tumors. Leading sponsors running trials in the state include University of Michigan, University of Michigan Rogel Cancer Center, National Cancer Institute (NCI). By stage, Michigan trials break down as Phase 1 (57), Phase 2 (97), Phase 3 (88), Phase 4 (10).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Michigan
Frequently Asked Questions — Clinical Trials in Michigan
How many clinical trials are currently recruiting in Michigan?
ClinicalMetric currently tracks 319 actively recruiting clinical trials with at least one location in Michigan. The total number of registered studies—including active but not currently enrolling trials—is 319. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Michigan?
Michigan hosts clinical trials across a broad range of medical conditions, including Prostate Cancer, Advanced Solid Tumor, Solid Tumors, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Michigan serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Michigan?
To join a clinical trial in Michigan, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Michigan maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Michigan
NCT07450547 Phase 2
Recruiting
Phase 2 Study to Assess the Safety and Efficacy of ANG003
Condition
Exocrine Pancreatic Insufficiency (EPI)
Enrollment
113 pts
Location
United States
Sponsor
Anagram Therapeutics, Inc.
NCT07645287 Phase 2
Recruiting
A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologica...
Condition
HIV-1-infection
Enrollment
175 pts
Location
United States, Australia, Canada
Sponsor
Gilead Sciences
NCT07424833 Phase 1
Recruiting
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
Condition
Relapsed/Refractory Hematological Malignancies
Enrollment
180 pts
Location
United States, China
Sponsor
Ascentage Pharma Group Inc.
NCT07507747 N/A
Recruiting
Testing an Adaptive Intervention for Peer-Supported Mobile Health for Primary Ca...
Condition
Psychological Distress
Enrollment
384 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT05922761 Phase 2
Recruiting
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
Condition
Bronchiolitis Obliterans Syndrome
Enrollment
45 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute
NCT07406633 Phase 2
Recruiting
KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIS...
Condition
GIST - Gastrointestinal Stromal Tumor
Enrollment
46 pts
Location
United States
Sponsor
Kumquat Biosciences Inc.
NCT04427384 N/A
Recruiting
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Condition
Brain Tumor, Recurrent
Enrollment
600 pts
Location
United States
Sponsor
GT Medical Technologies, Inc.
NCT06457503 Phase 4
Recruiting
A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Particip...
Condition
Nasopharyngeal Cancer Recurrent
Enrollment
100 pts
Location
United States, Canada
Sponsor
Coherus Oncology, Inc.
NCT07037459 Phase 3
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejecti...
Condition
Heart Failure With Preserved Ejection Fraction
Enrollment
5,056 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
NCT05101070 Phase 1, Phase 2
Recruiting
S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor i...
Condition
Solid Tumors
Enrollment
282 pts
Location
United States, Japan
Sponsor
Shionogi
NCT05338697 N/A
Recruiting
Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future...
Condition
Stroke
Enrollment
657 pts
Location
United States
Sponsor
Yale University
NCT06959524 N/A
Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Co...
Condition
Coronary Arterial Disease (CAD)
Enrollment
1,616 pts
Location
United States, Australia, China
Sponsor
Boston Scientific Corporation
NCT07782996 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of GSK5784283 Compared With Place...
Condition
Asthma
Enrollment
370 pts
Location
United States, Japan
Sponsor
GlaxoSmithKline
NCT07355062 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Me...
Condition
CKD
Enrollment
150 pts
Location
United States
Sponsor
Renibus Therapeutics, Inc.
NCT05431088 Phase 2, Phase 3
Recruiting
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
Condition
Sickle Cell Disease
Enrollment
389 pts
Location
United States, Brazil, India
Sponsor
Pfizer
NCT07294170 N/A
Recruiting
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and E...
Condition
Myasthenia Gravis
Enrollment
70 pts
Location
United States, Belgium, Germany
Sponsor
argenx
NCT06511141 N/A
Recruiting
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Condition
Overactive Bladder
Enrollment
150 pts
Location
United States
Sponsor
Axonics, Inc.
NCT03486873 Phase 3
Recruiting
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tum...
Condition
Solid Tumors
Enrollment
3,500 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT04812366 Phase 2
Recruiting
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Pr...
Condition
Prostate Cancer
Enrollment
315 pts
Location
United States, Canada
Sponsor
University of British Columbia
NCT07207707 Phase 1
Recruiting
A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Ad...
Condition
Solid Tumor Malignancies
Enrollment
78 pts
Location
United States
Sponsor
Kumquat Biosciences Inc.
NCT05465044 N/A
Recruiting
Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets)
Condition
Chronic Kidney Disease (CKD) Stage 5
Enrollment
252 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT06548360 Phase 3
Recruiting
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Pa...
Condition
NonSegmental Vitiligo
Enrollment
180 pts
Location
United States, Canada
Sponsor
Incyte Corporation
NCT06480383 Phase 2
Recruiting
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiet...
Condition
Generalized Anxiety Disorder
Enrollment
705 pts
Location
United States, Bulgaria, Czechia
Sponsor
Intra-Cellular Therapies, Inc.
NCT06172296 Phase 3
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Tre...
Condition
Ganglioneuroblastoma, Nodular
Enrollment
478 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
NCT06963827 Phase 3
Recruiting
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Condition
Kidney Disease
Enrollment
347 pts
Location
United States, Argentina, Australia
Sponsor
Takeda
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology